The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats

Dechra Regulatory B.V.VPA22622/014/001

Main Information

Trade NameIntubeaze 20 mg/ml laryngopharyngeal spray, solution for cats
Active SubstancesLidocaine Hydrochloride Monohydrate
Dosage FormLaryngopharyngeal spray, solution
Licence HolderDechra Regulatory B.V.
License Holder AddressHandelsweg 25
5531 AE Bladel
Licence NumberVPA22622/014/001

Group Information

ATC CodeQR02AD02 lidocaine
Therapeutic ClassAnaesthetic/Analgesic


License statusAuthorised
Licence Issued07/12/2018
Legal StatusVPO: Veterinary Practitioner Only as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back